Sarcopenia Treatment Market Segment, Companies, Trend & Growth Analysis 2025-30
Markntel Advisors’ report, Sarcopenia Treatment Research Report: Trend, Business Growth, Size, Future Scope, Segmentation, Dynamics, and Forecast to 2030, offers a comprehensive guide for the growing industry. The expert team of analysts dedicated significant effort to gathering and evaluating the latest market data, resulting in a detailed and up-to-date report that offers valuable insights for individuals who rely on data-driven decisions, including business owners and analysts. The research report on the Sarcopenia Treatment presents well-researched facts and figures pertinent to the industry, whether the goal is to explore new markets, launch a new product, or maintain a competitive advantage.
Sarcopenia Treatment Market Research Report & Market Summary:
The Global Sarcopenia Treatment Market size was valued at around USD 3 billion in 2024 and is projected to reach USD 3.9 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 4% during the forecast period, i.e., 2025-30. The Global Sarcopenia Treatment Market is experiencing significant growth driven by numerous key factors. Extended awareness of sarcopenia, particularly among aging populations, is encouraging early analysis and intervention. As a result, both healthcare specialists and patients are more actively managing muscle loss related to aging. Upgrades in nutritional supplements, which include amino acids, vitamin D, and protein-based products, are playing a pivotal function in fighting sarcopenia. These nutritional supplements are being more prescribed as a part of a holistic method of treatment, enhancing muscles and energy. Furthermore, government projects and healthcare programs for assisting the elderly people, are boosting the marketplace growth.
If you’re interested in the assumptions considered in this study, you can download the PDF brochure- https://www.marknteladvisors.com/query/request-sample/sarcopenia-treatment-market.html
Sarcopenia Treatment Market Dynamics:
Key Driver-
Increasing Global Aging Population – The Global Sarcopenia Treatment Market is majorly driven by the growing global aging population. The number of people more than 65 years old globally is projected to increase by double, rising from 761 million in 2021 to at least 1.6 billion in 2050. Due to this demographic trade sarcopenia, a situation that affects a massive percentage of older adults, and other age-associated illnesses are becoming usual. People begin losing nearly 3 to 8 percent of their muscular mass every ten years after the age of 30. Throughout their lives, maximum males will lose roughly 30% of their muscular mass. Sarcopenia has been mentioned to influence up to 15% of people aged between 60 to 70 years and as much as 50% of people over 80 years of age. This lack of muscle is a serious difficulty for older populations because it can result in increased frailty, disability, and a high chance of falls and fractures.
Thus, effective sarcopenia treatment options are becoming more important as the population ages to preserve independence, enhance mobility, and decrease medical charges related to the situation’s complications. Developing information on the sarcopenia affects elderly people is also demanding interventions like medicine, physical remedies, and dietary supplements.
Sarcopenia Treatment Market Segmentation Analysis:
According to MarkNtel study the market is segmented into the following categories:
By Treatment Type
- Protein Supplements – Market Size & Forecast 2020-2030F, USD Million
- Vitamin B12 Supplements – Market Size & Forecast 2020-2030F, USD Million
- Vitamin D and Calcium Supplements – Market Size & Forecast 2020-2030F, USD Million
Protein Supplements are the market leader in the Global Sarcopenia Treatment Market holding almost 50% of the total market because protein supplements directly support muscle health and prevent muscle loss. It has been demonstrated that taking supplements of protein which is essential for muscle can help prevent or slow the progression of sarcopenia especially in older adults.
By Diagnostic Method
- Biochemical Tests – Market Size & Forecast 2020-2030F, USD Million
- Imaging Techniques – Market Size & Forecast 2020-2030F, USD Million
- Functional Assessments – Market Size & Forecast 2020-2030F, USD Million
- Others – Market Size & Forecast 2020-2030F, USD Million
Functional assessments account for around 40% of the Global Sarcopenia Treatment Market. It is the most popular way to diagnose sarcopenia by concentrating on analyzing a person’s physical performance and muscle function.
By Distribution Channel
- Hospital Pharmacies Source – Market Size & Forecast 2020-2030F, USD Million
- Retail Pharmacies Source – Market Size & Forecast 2020-2030F, USD Million
- Online Pharmacies Source – Market Size & Forecast 2020-2030F, USD Million
- Other – Market Size & Forecast 2020-2030F, USD Million
By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific.
North America is the market leader with around 40% share of the market for sarcopenia treatments worldwide because of its aging population, sophisticated healthcare system, and high sarcopenia awareness. With over 55 million people of age 65 and older in 2020 the United States in particular had the largest elderly population in the world.
As indicated in the latest market research report published by Markntel Advisors, “Sarcopenia Treatment Research Report: Forecast (2025-2030)”, this report offers a detailed analysis of the industry, featuring insights into the Sarcopenia Treatment industry. It encompasses competitor and geographical analyses, as well as recent advancements in the market.
Browse Full Report Along with TOC and Figures – https://www.marknteladvisors.com/research-library/sarcopenia-treatment-market.html
Top Companies Operating in the Sarcopenia Treatment Market:
- Pfizer Inc.
- Yeast Zydus Cadila, Ltd.
- Angel Yeast
- Makers Nutrition LLC
- Metabolic Technologies Inc.
- Metagenics LLC
- Haleon Group of Companies
- Abbott Laboratories
- Nestlé SA
- Eli Lilly
- Sanofi Inc.
- Novartis AG
- Amway Corporation
- Bayer AG
*Reports Delivery Format – Market research studies from MarkNtel Advisors are offered in PDF, Excel, and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address*
Other Report:
- The Data Integration Market is projected to grow from USD 14.23 billion in 2024to USD 30.87 billion by 2030, with a CAGR of 13.78% during 2025-2030.
- The Global Graph Database Market, valued at USD 3.12 billion in 2024, is projected to grow at a 23.56% CAGR from 2025-30, driven by AI tools and low-latency query processing.
Key Report Highlights:
- Market Dimensions & Projections
- Pricing Evaluation,
- Recent Strategic Moves by Companies,
- Primary Stakeholders,
- Analysis of Import and Export Trends,
- Competitive Landscape Assessment,
- Emerging Opportunities,
- Market Trends and Indicators
Note – If there are any particular details you need that are not currently included in the report, we will be happy to provide them as part of our customization services.
Frequently Asked Questions (FAQs)-
- What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
- What are the trends influencing the current scenario of the market?
- What leading factors would propel and impede the industry across the geography?
- How has the industry been evolving in terms of geography & Sarcopenia Treatment Market adoption?
- How has the competition been shaping up across the geography?
- Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?
About Us –
We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
Contact Us –
Call + +1 628 895 8081, +91 120 4278433
Email: sales@marknteladvisors.com
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
